Most Recent Discussions
Sep 25 2020
Re: Rocklatan FDA Approved
Curious, I just started a patient (my first with this therapy) on Rocklatan after getting ZERO IOP change on generic Xalatan. He has been using it correctly for no more than two weeks but is complaining of bloodshot eyes. Is
read more
Clinician Topics
- Glaucoma Watch
- Interesting Glaucoma Cases
- From Ocular Hypertension to Glaucoma: How to Predict Conversion
- Neckties and IOP: The Controversy Continues
- Introduction to the National Glaucoma Society
- Case Presentation: Optic Nerve Imaging
- NGS Residency Award and Lecture
- Optic Nerve Head Measurements with the HRT III
- Case Presentation: Laser Imaging Detects Early ON Damage
- Is the Optic Disc "Sinking" or "Cupping" in Glaucoma?
- Interview with Dr. Barry Barresi
- Glaucoma Continuum
- Undiagnosed Open Angle Glaucoma: The Thessaloniki Eye Study
- The Prevalence of Open-angle Glaucoma Among Blacks and Whites 73 Years and Older
- Altered Nitric Oxide System in Patients with Open-Angle Glaucoma
- Oxidative Stress in Glaucoma: A Burden of Evidence
- Gonioscopy Videos
- Glaucoma Risk and the Consumption of Fruits and Vegetables in Older Women
- Programs to Optimize Adherence in Glaucoma
- Corneal Hysteresis
- Visual Field Interpretation
- Study Questions link between Glaucoma and Alzheimer's Disease
- Checking Color Vision
- IOP Asymmetry as Glaucoma Risk Factor
- Glaucoma Risk Calculators
- Dr. David Calkins Discusses Catalyst for A Cure
- Smart Phone Biosensor
- Handheld OCT
- Sustained Release IOP Therapies
- Introduction to Corneal Hysteresis
- FDT Perimetry
- Visual Fields Overview
- National Glaucoma Symposium 2017
- Gonioscopy Slides from 2017 National Glaucoma Symposium
- Measuring Corneal Hysteresis
- XEN Glaucoma Implant Video
- Corneal Hysteresis
- Glaucoma Quality of Life Measures
- Corneal Hysteresis: The A1C of Glaucoma
- Predicting Progression
- New Developments in Glaucoma Management
- SECO Session on Innovations in Glaucoma
- Longitudinal Study of Corneal Hysteresis
- National Glaucoma Symposium 2018
- DREAM Study
- OIS at SECO
- National Glaucoma Symposium Cape Cod
- Is Glaucoma a Two-Pressure Disease?
- ICD Stage Definitions
- Visual Fields and Progression
- OCT: The Basics
- Co-Managing Glaucoma Surgery
- Normal Tension Glaucoma
- The Importance of Visual Fields
- Corneal Hysteresis
- Using OCT in Glaucoma Management
- The LiGHT Study
- Durysta Overview
- Options in Glaucoma Surgery
- Telemedicine in Glaucoma
- Glaucoma Medications
- In Your Office
- Glaucoma Flowsheet
- Tonometer Calibration
- Pachymetry Coding
- BCBS Coverage of SCODI Services
- Expanded Coverage of Glaucoma Screening Services
- Coding Update: 92135 Deleted and Replaced
- ABO Certification Review Materials
- Small Fee Reduction in CMS Payments in 2015
- Moist Heat Compresses
- Information about Omega-3s
- Glaucoma Website for Patients
- Beware of Phone Scam Posing as DPH or DEA
- Tonography
- Patient Assistance Programs
- Plaquenil Reporting Form
- Pharmacology Update
- Extravan: Alcon Pharmaceuticals
- Mechanism of IOP Reduction with Travoprost
- Hydroxychloroquine Toxicity
- Timolol
- Upneeq Drops for Ptosis
- Clinical Guidelines
- CCT: Is is time to say YES?
- The Role of CCT in Glaucoma Patients
- More CCT
- The Paradox of IOP
- Should We Treat All Ocular Hypertensives?
- Beta Blockers in Glaucoma Management
- Re-Defining Ocular Hypertension
- Implications of Macro-Disc Asymmetry in Glaucoma Suspects
- Nine-Year Changes in Intraocular Pressure: The Barbadoes Eye Studies
- CyPass Clinical Recommendations
- Optic Disc Cupping and Neuroimaging
- Industry News
- New FDA Approval for Lumigan
- Alcon's Travatan Z Solution Receives FDA Approval
- Alcon's Travatan Z and Systane Use Different Preservatives
- Pfizer Sponsors New "All Eyes on Glaucoma" Website
- CLIA Waivers
- Bausch + Lomb New Glaucoma Drug
- Glaukos iStent inject FDA Approved
- Alcon Withdraws CyPass Stents
- Nuretin Omega-3 Supplements
- Rocklatan FDA Approved
- Vivid Vision Perimetry
- Falck Multifunction Device